Today: 25 June 2026
Browse Category

Stock Market 30 January 2026

Microsoft stock extends post-earnings slide as AI spending debate heats up

Microsoft stock extends post-earnings slide as AI spending debate heats up

Microsoft shares fell 0.9% to $429.73 Friday, extending a sharp selloff that erased over $350 billion in value after disappointing cloud and spending updates. The company reported $81.3 billion in quarterly revenue and a 66% jump in capital spending, with two-thirds spent on chips. Microsoft also announced a $750 million, three-year AI deal with Perplexity AI to run on Azure.
Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple stock heads into next week with one big question: can AAPL dodge the memory-chip crunch?

Apple shares rose 0.6% to $259.92 in late Friday trading after the company projected fiscal Q2 revenue growth of 13–16%, beating analyst estimates. CEO Tim Cook cited strong iPhone demand but warned of processor supply issues and a global DRAM shortage expected to pressure margins. Apple reported quarterly revenue of $143.8 billion and EPS of $2.84. The company also acquired audio AI startup Q.ai for about $1.6 billion.
Sandisk stock price jumps after AI-fueled outlook; Kioxia deal and analyst calls in focus

Sandisk stock price jumps after AI-fueled outlook; Kioxia deal and analyst calls in focus

Sandisk shares rose 4.9% to $565.99 Friday after the company forecast Q3 revenue of $4.4–$4.8 billion and adjusted EPS of $12–$14, beating analyst estimates. Fiscal Q2 revenue climbed 31% to $3.03 billion, with gross margin at 50.9%. Sandisk and Kioxia extended their Japan joint venture through 2034, with Sandisk set to pay $1.165 billion between 2026 and 2029.
Unity Software stock tumbles as Google’s Project Genie sparks fresh game-engine jitters

Unity Software stock tumbles as Google’s Project Genie sparks fresh game-engine jitters

Unity shares plunged 25.7% to $28.53 late Friday after Google unveiled an AI model that generates interactive digital worlds, sparking a selloff across videogame stocks. Trading volume in Unity hit 78.4 million shares. Take-Two Interactive fell about 10%, and Roblox slid over 12%. Investors are watching Unity’s February 11 earnings for signals on demand and AI strategy.
PennyMac Financial Services stock plunges 33% after earnings miss hits servicing income

PennyMac Financial Services stock plunges 33% after earnings miss hits servicing income

PennyMac Financial shares plunged 33% to $100.39 Friday after fourth-quarter results showed servicing pretax income fell 70% to $37.3 million. Lower mortgage rates triggered faster prepayments, eroding servicing profits. Net income for the quarter was $106.8 million, or $1.97 per share, missing analyst forecasts. Piper Sandler cut its price target on the stock to $137.
Cavco stock slides nearly 19% after earnings miss; what CVCO investors watch next

Cavco stock slides nearly 19% after earnings miss; what CVCO investors watch next

Cavco Industries shares fell 19% to $501.03 after fiscal Q3 earnings missed expectations, despite an 11.3% revenue rise to $581 million. EPS dropped to $5.58 from $6.90 a year earlier, with margins pressured by higher costs and weaker industry shipments. The company cited a $42 million revenue boost from its American Homestar acquisition but noted increased expenses.
Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck stock rises as markets wobble — what to watch before the Feb. 3 earnings call

Merck shares rose 1.2% to $109.64 Friday afternoon, outperforming a falling S&P 500. Health care stocks attracted buyers as inflation data came in hotter than expected and Donald Trump named Kevin Warsh as Federal Reserve chair. Investors are watching for Merck’s Feb. 3 earnings call, with focus on 2026 guidance and Keytruda sales trends.
Eaton stock slides late Friday as ETN investors weigh AI data-center push, earnings next week

Eaton stock slides late Friday as ETN investors weigh AI data-center push, earnings next week

Eaton shares fell 0.9% to $351.32 Friday after U.S. inflation data and a new Fed nomination rattled markets. The company, active in AI power-supply, will report Q4 earnings Feb. 3 and discuss plans to spin off its Mobility business by Q1 2027. Trading volume topped the 50-day average Thursday as Eaton closed up 2.03%. Investors await 2026 guidance and updates on electrical segment orders.
USA Rare Earth (USAR) stock rebounds after chairman buy as Washington price-floor rethink rattles rare-earths

USA Rare Earth (USAR) stock rebounds after chairman buy as Washington price-floor rethink rattles rare-earths

USA Rare Earth shares rose 1.4% to $22.37 Friday after chairman Michael Blitzer disclosed buying 100,000 shares on Jan. 29. The company this week raised $1.5 billion through a PIPE led by Inflection Point. Trading volume topped 26 million shares amid shifting U.S. signals on critical-minerals price support. The stock briefly jumped nearly 12% before paring gains.
30 January 2026
Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive stock price jumps 5% after earnings beat and upbeat 2026 sales forecast

Colgate-Palmolive shares rose 5.2% to $89.70 Friday after the company beat Q4 profit forecasts and projected 2026 net sales growth of 2% to 6%. A $794 million after-tax impairment charge pushed GAAP results to a quarterly loss. Q4 net sales reached $5.23 billion, with adjusted earnings of 95 cents per share. Demand held steady in Latin America and Europe, while North American volumes stayed flat.
SLB stock price today: Shares dip as Oman contract win meets oil-market nerves

SLB stock price today: Shares dip as Oman contract win meets oil-market nerves

SLB shares fell 0.3% to $48.30 Friday afternoon, extending earlier losses and trading below their January peak. The company announced two five-year equipment contracts in Oman’s Block-6, while traders watched oil prices and awaited U.S. drilling data. About 10.8 million shares changed hands. OPEC+ is expected to keep output steady at its meeting Sunday, according to delegates.
Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings (HTH) stock climbs after dividend hike, new $125 mln buyback and Q4 profit lift

Hilltop Holdings shares rose 2.9% to $37.87 Friday after the company reported a Q4 profit of $41.6 million and raised its quarterly dividend to $0.20 per share. The board approved a new $125 million stock buyback plan through January 2027. Mortgage originations reached $2.4 billion for the quarter. The bank set aside $7.8 million for credit losses as non-accrual loans declined.
Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week

Starbucks stock drops near $92 as investors weigh 2028 margin push after a busy week

Starbucks shares fell about 2% Friday, trading near $92 after a volatile week. Fiscal Q1 net revenue rose 6% to $9.9 billion, with adjusted EPS at $0.56 and global same-store sales up 4%, but operating margin dropped to 10.1%. The company forecast 2026 adjusted EPS of $2.15–$2.40 and plans to close its China retail joint venture this spring. Investors remain focused on margin improvement and upcoming results.
30 January 2026
ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX

ImmunityBio stock rebounds: FDA scrutiny, a $505 million note and the next catalyst for IBRX

ImmunityBio shares climbed 5.9% to $6.26 Friday, rebounding from early losses despite declines in major biotech ETFs. The move followed a STAT News report that Chairman Patrick Soon-Shiong misrepresented an FDA meeting on Anktiva’s label expansion. Investors also tracked dilution risk after ImmunityBio amended a $505 million convertible note to allow partial conversions into stock.
30 January 2026
Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products stock jumps 6% after earnings beat guidance — what APD investors watch next

Air Products and Chemicals shares rose 6.2% to $271.89 after fiscal Q1 adjusted EPS reached $3.16, beating estimates and topping guidance. Revenue climbed 6% to $3.1 billion. The company held its FY2026 adjusted EPS forecast at $12.85–$13.15 and expects capex near $4 billion. Helium weakness continued to weigh on volumes and pricing, especially in Asia.

Stock Market Today

  • Judo Capital (ASX:JDO) Stock Drops 40% Amid Heavy Trading on June 2024
    June 25, 2026, 11:25 AM EDT. Shares of Judo Capital Holdings Limited (ASX:JDO) plunged 40.39% to AUD 0.915, with trading volume surging to 98.1 million shares, well above average. The Australian banking sector lender experienced high intraday volatility, ranging from AUD 0.820 to AUD 1.170, signaling strong investor reaction and sell-off pressure. Judo Capital operates in SME lending, sensitive to broader credit conditions and interest rate changes. The sharp decline reflects market concerns over credit quality and funding costs, although the company targets niche lending opportunities. With a market capitalization near AUD 1.72 billion, the stock's fall highlights increased risk perception amid volatile credit market trends and competitive pressures within the banking sector.

Latest News

US stocks now: Broad gains balance $416 billion drop in megacap tech

US stocks now: Broad gains balance $416 billion drop in megacap tech

25 June 2026
Apple, Nvidia, Microsoft, Alphabet, and Meta lost about $416 billion in combined market value as investors rotated into Dow and small-cap stocks, with Apple dragging after raising MacBook and iPad prices due to higher memory costs; meanwhile, Micron surged 10.4% on strong earnings and guidance, and Qualcomm gained 3.6% after boosting long-term revenue targets.
Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

Bio-Techne soars after Merck offer at $73 a share; spread remains on cash bid

25 June 2026
Bio-Techne surged 19% to $70.17 after Merck KGaA’s $73 per share cash offer, leaving a $2.83 spread as the deal awaits shareholder and regulatory approval, with closing expected in late 2026 or early 2027; trading volume soared past short interest, and the deal values Bio-Techne at $11.3 billion, less than 9.4 times fiscal 2025 sales.
Go toTop